Should we revascularize patients with moderate coronary lesions and borderline fractional flow reserve measurements?
Zijlstra
Felix
F
Thorax Center, University Medical Center, Groningen. f.zijlstra@thorax.umcg.nl
D000787:Angina Pectoris / Q000209:etiology; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000009:adverse effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D023921:Coronary Stenosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D053805:Fractional Flow Reserve, Myocardial; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology* / Q000401:mortality; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
D002317:Cardiovascular Agents